Martha M. Wright

Martha M. Wright

Auto-generated profile, based on publicly available information

Martha M. Wright

Department of Ophthalmology & Visual Neurosciences, University of Minnesota-Minneapolis, Minneapolis, Minnesota

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2018 in Ophthalmology
Verified
Journal Article
Closed access
SGSteven J. Gedde
Steven J. Gedde
PCPhilip P. Chen
Philip P. Chen
DHDale K. Heuer
Dale K. Heuer
KSKuldev Singh
Kuldev Singh
MWMartha M. Wright
Martha M. Wright
WSWei Shi
Wei Shi

30 August 2022 in Journal of Current Glaucoma Practice
Verified
Journal Article
Open access
YZYujia Zhou
Yujia Zhou
SCSydni Coleman
Sydni Coleman
JBJess Boysen
Jess Boysen
MPMorgan L Pansegrau
Morgan L Pansegrau
MWMartha M Wright
Martha M Wright
KAKaren Armbrust
Karen Armbrust
The study purpose was to assess patient survival after tube shunt implant or cyclodestructive procedure for neovascular glaucoma and to determine whether specific preoperative factors are predictive of survival. A retrospective chart review was performed on patients with neovascular glaucoma who underwent tube shunt implant and/or cyclodestructive procedure between January 2002 and December 2019 at the Minneapolis Veterans Affairs Health Care System. Patient survival was compared to the age and gender-matched Minnesota population. Cox regression analyses were performed to evaluate preoperative parameters and survival. Tube shunt alone was implanted in 30 eyes, cyclodestruction alone was performed in nine eyes, and two eyes underwent both (n = 41 eyes, 39 patients). The postoperative 5-year survival rate was 62% in neovascular glaucoma patients compared to 80% in controls. Survival did not differ significantly based on neovascular glaucoma etiology. Preoperative best-corrected visual acuity of the neovascular glaucoma-affected eye (p = 0.05) and Charlson Comorbidity Index (p = 0.02) were associated with survival, but preoperative maximum intraocular pressure, hemoglobin A1c, and creatinine were not. The mean intraocular pressure at 6 months postprocedure was 14 mm Hg for tube shunt and 27 mm Hg for cyclodestruction (p = 0.03). Neovascular glaucoma patients have reduced survival, but the majority survived at least 5-year postprocedure. Ophthalmologists should consider patient survival and factors predictive of survival when planning procedures for neovascular glaucoma. Our findings provide an updated perspective on survival in the setting of neovascular glaucoma and can help ophthalmologists provide patient-centered and holistic care. Zhou Y, Coleman S, Boysen J, et al. Survival in Patients with Neovascular Glaucoma Following Tube Shunt Implant or Cyclodestructive Procedure. J Curr Glaucoma Pract 2022;16(2):74-78.

1 September 2020 in Ophthalmology Glaucoma
Verified
Journal Article
Closed access
DMDanny A. Mammo
Danny A. Mammo
MSMargaret Strampe
Margaret Strampe
ANAmeay Naravane
Ameay Naravane
PMPaul W. Mallory
Paul W. Mallory
JBJess Boysen
Jess Boysen
MWMartha M. Wright
Martha M. Wright